"Amyloid immunotherapy has consistently shown an increase in brain volume loss – leading to concerns in the media and medical ...

Men at high risk of cardiovascular disease had brain volume changes a decade earlier than women, U.K. Biobank data showed.

EXCLUSIVE: UCL researchers argue that loss of brain volume may in fact be a sign that the treatments are working.

A new study indicates that the loss of brain volume associated with the Alzheimer's drug lecanemab shows the drug is working ...

Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques ...

Here are five brain facts that are now brain fiction.

Obesity and cardiovascular risk factors accelerate brain volume loss, with males experiencing earlier and more significant ...

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid ...

Men with cardiovascular disease risk factors, including obesity, may face earlier brain health decline compared to women up ...

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study ...